(Q39181648)

9 September 2017

Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study (English)

1 reference

9 September 2017

0 references

0 references

1 reference

17

1 reference

9 September 2017

1

0 references

Silvana Guerriero

object named as

Silvana Guerriero

6

0 references

Giacomo Emmi

object named as

Giacomo Emmi

3

0 references

Mauro Galeazzi

13

object named as

Mauro Galeazzi

1 reference

9 September 2017

16

Carlo Salvarani

1 reference

9 September 2017

12

Bruno Frediani

1 reference

9 September 2017

15

Gian Marco Tosi

1 reference

9 September 2017

5

Giuseppe Lopalco

1 reference

9 September 2017

4

Lorenzo Vannozzi

1 reference

9 September 2017

9

Daniela Bacherini

1 reference

9 September 2017

14

Florenzo Iannone

1 reference

9 September 2017

Antonio Vitale

2

1 reference

9 September 2017

Ida Orlando

7

1 reference

9 September 2017

Rossella Franceschini

8

1 reference

9 September 2017

Luca Cimino

10

1 reference

9 September 2017

Alessandra Soriano

11

1 reference

9 September 2017

language of work or name

1 reference

16 November 2016

1 reference

9 September 2017

Clinical Rheumatology

1 reference

9 September 2017

36

1 reference

9 September 2017

1

1 reference

9 September 2017

183-189

1 reference

Ocular features of Behcet's disease: an international collaborative study

9 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Uveitis in Behçet disease: an analysis of 880 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Controversies in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Management of Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Anti-tumor necrosis factor-α therapy in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Local (topical and intraocular) therapy for ocular Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Clinical experience with adalimumab in the treatment of ocular Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Adalimumab for sight-threatening uveitis in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Adalimumab for the treatment of Behçet's disease: experience in 19 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Outcome measures used in clinical trials for Behçet syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Development of de novo major involvement during follow-up in Behçet’s syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3480-X

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 January 2018

1 reference

12 December 2020

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy

1 reference

12 December 2020

Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis

1 reference

12 December 2020

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis

1 reference

12 December 2020

Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.

1 reference

12 December 2020

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab

1 reference

12 December 2020

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

1 reference

12 December 2020

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

1 reference

12 December 2020

[Efficacy of adalimumab in Behçet's disease. Description of 6 cases]

1 reference

12 December 2020

Behçet's syndrome: a critical digest of the 2013-2014 literature.

1 reference

12 December 2020

Empiricism in managing Behçet's syndrome

1 reference

12 December 2020

10.1007/S10067-016-3480-X

Identifiers

DOI

1 reference

9 September 2017

1 reference